Meeting highlights: National Cancer Institute workshop on molecular signatures of infectious agents

Disease Markers

Volumn 17, Issue 3, 2001, Pages 191-201

  Verma, M ^a   Lambert, P F ^a   Srivastava, S K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CANCER VACCINE; GENE PRODUCT;

CANCER; CANCER DIAGNOSIS; CANCER IMMUNIZATION; CANCER PREVENTION; CARCINOGENESIS; DNA REPAIR; DNA REPLICATION; EPSTEIN BARR VIRUS; FUNGUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS G VIRUS; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 8; HUMAN T CELL LEUKEMIA VIRUS; IMMUNE RESPONSE; JC VIRUS; POLYOMA VIRUS; PRIORITY JOURNAL; REVIEW; TRANSACTIVATION; VIRUS DETECTION; VIRUS GENE; WART VIRUS;

FUNGI; GB VIRUS C/HEPATITIS G VIRUS; HEPATITIS B VIRUS; HERPESVIRIDAE; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS TYPES; JC VIRUS; POLYOMAVIRUS;

EID: 0035666363     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2001/986049     Document Type: Review

References (83)

1. Thematic review series. XI: Viruses in the origin of human cancer. Introduction and overview
2. Higher prevalence and viral load of TT virus in saliva than in the corresponding serum: Another possible transmission route and replication site of TT virus
3. Seroepidemiology of TT virus, GBC-C/HGV, and hepatitis viruses B, C, and E among women in a rural area of Tanzania
4. Potential dengue virus-triggered apoptotic pathway in human neuroblastoma cells: Arachidonic acid, superoxide anion, and NF-kappaB are sequentially involved
5. Infections and human cancer
6. Infections as a major preventable cause of human cancer
7. The human polyomaviruses, BKV and JCV: Molecular pathogenesis of acute disease and potential role in cancer
8. Vaccination against infectious agents associated with human cancer
9. Cancer and infection: Estimates of the attributable fraction in 1990
10. Microarray analysis identifies interferon-inducible genes and STAT-1 as major transcriptional targets of human papillomavirus type 31
11. A novel JC virus variant found in the highlands of Papua New Guinea has a 21-base pair deletion in the agnoprotein gene
12. JC virus DNA is present in the mucosa of the human colon and in colorectal cancers
13. Quantification of human polyomavirus JC in brain tissue and cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy by competitive PCR
14. Use of a TT virus ORF1 recombinant protein to detect anti-TT virus antibodies in human sera
15. Three spliced mRNAs of TT virus transcribed from a plasmid containing the entire genome in COS1 cells
16. Establishment of the human papillomavirus type 16 (HPV-16) life cycle in an immortalized human foreskin keratinocyte cell line
17. The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle
18. Human papillomavirus oncoproteins E6 and E7 independently abrogate the mitotic spindle checkpoint
19. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells
20. Chromosome fragility and instability in human cancer
21. Recurrent integration of papillomavirus DNA within the human 12q14-15 uterine breakpoint region in genital carcinomas
22. The E8E2C protein, a negative regulator of viral transcription and replication, is required for extrachromosomal maintenance of human papillomavirus type 31 in keratinocytes
23. Differentiation-induced changes in promoter usage for transcripts encoding the human papillomavirus type 31 replication protein E1
24. Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes
25. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes
26. Breast cancer: A new Epstein-Barr virus-associated disease?
27. Species-specific TT viruses in humans and nonhuman primates and their phylogenetic relatedness
28. TT virus infection in patients with chronic liver disease of unknown etiology
29. TT virus infection in Japanese children: Isolates from genotype 1 are overrepresented in patients with hepatic dysfunction of unknown etiology
30. Hepatitis B virus and liver cancer: Unanswered questions
31. The cellular response of JC virus T-antigen-induced brain tumor implants to a Murine intraocular model
32. Detection of human neurotropic JC virus DNA sequence and expression of the viral oncogenic protein in pediatric medulloblastomas
33. Disturbance of the normal cell cycle by T antigens of SV40 viruses and JC cause some tumors
34. JC virus binds to primary human glial cells, tonsillar stromal cells, and B-lymphocytes, but not to T lymphocytes
35. JC virus DNA sequences are frequently present in the human upper and lower gastrointestinal tract
36. Is JC polyomavirus the cause of ulcerative colitis and multiple sclerosis?
37. Suppression of DNA repair by HTLV type 1 tax correlates with tax trans-activation of proliferating cell nuclear antigen gene expression
38. T-cell lines established from human T-lymphocytic neo-plasias by direct response to T-cell growth factor
39. Disruption of nucleotide excision repair by the human T-cell leukemia virus type 1 Tax protein
40. Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the co-activator CBP
41. Augmentation of human T cell leukaemia virus type I Tax transactivation by octamer binding sites
42. Human T-cell leukemia virus type 1 Tax transactivates the human proliferating cell nuclear antigen promoter
43. Sequences flanking the cAMP responsive core of the HTLV-I tax response elements influence CREB protease sensitivity
44. Dissociation of DDB1-binding and transactivation properties of the hepatitis B virus X protein
45. Expression of hepatitis B virus X protein does not alter the accumulation of spontaneous mutations in transgenic mice
46. Hepatitis B virus X protein interferes with cellular DNA repair
47. Identification of the novel K15 gene at the rightmost end of the Kaposi's sarcoma-associated herpesvirus genome
48. Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein
49. Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12)
50. Kaposi's sarcoma among persons with AIDS: A sexually transmitted infection?
51. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
52. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins
53. Multiplex polymerase chain reaction for the simultaneous detection and typing of polyomavirus JC, BK and SV40 DNA in clinical samples
54. Simian virus 40 DNA sequences in human brain and bone tumours
55. SV40 as an oncogenic virus and possible human pathogen
56. SV40 as a putative human commensal
57. SV40 and human brain tumors
58. Epstein-Barr virus (EBV) nuclear antigen (EBNA)-4 mutation in EBV-associated malignancies in three different populations
59. A longitudinal study of HPV detection and cervical pathology in HIV infected women
60. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome
61. Routine versus selective antifungal administration for control of fungal infections in patients with cancer
62. Lymphoid proliferations and lymphomas associated with gastric metaplasia, dysplasia, and carcinoma
63. Individual and joint contribution of family history and Helicobacter pylori infection to the risk of gastric carcinoma
64. Relationship between schistosomiasis and bladder cancer
65. Clinical implications of TT virus superinfection in patients with chronic hepatitis C
66. TTV positivity and transfusion history in non-B, non-C hepatocellular carcinoma compared with HBV- and HCV-positive cases
67. Effect of TT virus infection on hepatocellular carcinoma development: Results of a Euro-Asian survey
68. Genomes and proteomes: Towards a multidimensional view of biology
69. New approaches to molecular profiling of tissue samples
70. Beyond the genome to the proteome
71. Proteomics: Capacity versus utility
72. A two-dimensional electrophoresis database of human breast epithelial cell proteins
73. Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: Implications for the development of broad spectrum anti-hepatitis virus agents
74. Role of glycan processing in hepatitis B virus envelope protein trafficking
75. The role of N-linked glycosylation in the secretion of hepatitis B virus
76. Hepatitis C virus
77. Sample preparation of human tumors prior to two-dimensional electrophoresis of proteins
78. Strategies to reduce the risk of virus-related cancers
79. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways
80. A long-term memory obtained by genetic immunization results in full protection from a mammary adenocarcinoma expressing an EBV gene
81. Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy
82. Kaposi's sarcoma